Completed NA INTERVENTIONAL 2-arm NCT05726929

Algology in Oncology Osteopathic Support (ALGOS) (ALGOS)

Algology in Oncology Osteopathic Support

Sponsor: Institut Claudius Regaud

Conditions Breast Cancer Neuropathic Pain

Interventions Capsaicin QUTENZA Patch (TAU) Osteopathic treatment

Updated 4 times since 2023 Last updated: Feb 14, 2025 Started: Jan 11, 2023 Primary completion: Dec 8, 2024 Completion: Dec 8, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Breast Cancer and Neuropathic Pain, this trial is completed. The trial is conducted by Institut Claudius Regaud and has accumulated 4 data snapshots since 2023. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Mar 2025 — Present [monthly]

Completed NA

Status: Recruiting → Completed
Sep 2024 — Mar 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Mar 2023 — Jul 2024 [monthly]

Recruiting NA

First recorded

Jan 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institut Claudius Regaud
Institut Toulousain d'Ostéopathie

Data source: Institut Toulousain d'Ostéopathie

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toulouse, France